These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 8914106

  • 1. Intrafamilial variability in Machado-Joseph disease.
    Subramony SH, Currier RD.
    Mov Disord; 1996 Nov; 11(6):741-3. PubMed ID: 8914106
    [Abstract] [Full Text] [Related]

  • 2. Dominantly inherited cerebello-olivary atrophy is not due to a mutation at the spinocerebellar ataxia-I, Machado-Joseph disease, or Dentato-Rubro-Pallido-Luysian atrophy locus.
    Subramony SH, Fratkin JD, Manyam BV, Currier RD.
    Mov Disord; 1996 Mar; 11(2):174-80. PubMed ID: 8684388
    [Abstract] [Full Text] [Related]

  • 3. Dominantly inherited ataxias: lessons learned from Machado-Joseph disease/spinocerebellar ataxia type 3.
    Paulson HL.
    Semin Neurol; 2007 Apr; 27(2):133-42. PubMed ID: 17390258
    [Abstract] [Full Text] [Related]

  • 4. Levodopa-responsive rubral (Holmes') tremor.
    Vélez M, Cosentino C, Torres L.
    Mov Disord; 2002 Jul; 17(4):741-2. PubMed ID: 12210864
    [No Abstract] [Full Text] [Related]

  • 5. Muscle excitability abnormalities in Machado-Joseph disease.
    França MC, D'Abreu A, Nucci A, Lopes-Cendes I.
    Arch Neurol; 2008 Apr; 65(4):525-9. PubMed ID: 18413477
    [Abstract] [Full Text] [Related]

  • 6. Machado-Joseph disease in New England: clinical description and distinction from the olivopontocerebellar atrophies.
    Sudarsky L, Corwin L, Dawson DM.
    Mov Disord; 1992 Apr; 7(3):204-8. PubMed ID: 1620136
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Trimethoprim-sulfamethoxazole and biopterin treatment in Machado-Joseph disease.
    Sakai T.
    Mov Disord; 1998 May; 13(3):622. PubMed ID: 9613774
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Spinocerebellar ataxia type 3: response to levodopa infusion in two cases.
    Miranda J, Cubo E.
    Neurol Sci; 2022 May; 43(5):3423-3425. PubMed ID: 35199253
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dopaminergic response in Parkinsonian phenotype of Machado-Joseph disease.
    Buhmann C, Bussopulos A, Oechsner M.
    Mov Disord; 2003 Feb; 18(2):219-21. PubMed ID: 12539220
    [Abstract] [Full Text] [Related]

  • 13. Levodopa can worsen tremor associated with dystonia.
    Hensman DJ, Bain PG.
    Mov Disord; 2006 Oct; 21(10):1778-80. PubMed ID: 16856131
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the effect of sulphametoxazole and trimethoprim in patients with Machado-Joseph disease.
    Correia M, Coutinho P, Silva MC, Guimarães J, Amado J, Matos E.
    Rev Neurol; 1995 Oct; 23(121):632-4. PubMed ID: 8597984
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
    Hauser RA, Koller WC, Hubble JP, Malapira T, Busenbark K, Olanow CW.
    Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.